Anti-Obesity Prescription Market Size, Share, Trends, Growth, and Forecasts for 2025 - 2032

Table of Content

1. Executive Summary
   1. Global Anti-Obesity Prescription Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. COVID-19 Impact Analysis
   4. Forecast Factors - Relevance and Impact
3. Value Added Insights
   1. Value Chain Analysis
   2. Key Market Players
   3. Regulatory Landscape
   4. PESTLE Analysis
   5. Porter’s Five Force Analysis
   6. Consumer Behavior Analysis
4. Price Trend Analysis, 2019 - 2032
   1. Key Factors Impacting Product Prices
   2. Pricing Analysis, By Product Type
   3. Regional Prices and Product Preferences
5. Global Anti-Obesity Prescription Market Outlook
   1. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, 2025-2032
   2. Global Anti-Obesity Prescription Market Outlook: Product Type
      1. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
         1. Approved Drugs
         2. Off Label Drugs
      3. Market Attractiveness Analysis: Product Type
   3. Global Anti-Obesity Prescription Market Outlook: Mechanism
      1. Historical Market Size (US$ Bn) Analysis, By Mechanism, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
         1. Peripherally Acting Drugs
         2. Centrally Acting Drugs
      3. Market Attractiveness Analysis: Mechanism
   4. Global Anti-Obesity Prescription Market Outlook: Distribution Channel
      1. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2019-2024
      2. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
         1. Retail Pharmacies
         2. Hospitals Pharmacies
         3. Others
      3. Market Attractiveness Analysis: Distribution Channel
6. Global Anti-Obesity Prescription Market Outlook: Region
   1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2024
   2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2025-2032
      1. North America
      2. Latin America
      3. Europe
      4. East Asia
      5. South Asia and Oceania
      6. Middle East & Africa
   3. Market Attractiveness Analysis: Region
7. North America Anti-Obesity Prescription Market Outlook
   1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product Type
      3. By Mechanism
      4. By Distribution Channel
   2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. U.S.
      2. Canada
   3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      1. Approved Drugs
      2. Off Label Drugs
   4. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
      1. Peripherally Acting Drugs
      2. Centrally Acting Drugs
   5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Retail Pharmacies
      2. Hospitals Pharmacies
      3. Others
   6. Market Attractiveness Analysis
8. Europe Anti-Obesity Prescription Market Outlook
   1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product Type
      3. By Mechanism
      4. By Distribution Channel
   2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
   3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      1. Approved Drugs
      2. Off Label Drugs
   4. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
      1. Peripherally Acting Drugs
      2. Centrally Acting Drugs
   5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Retail Pharmacies
      2. Hospitals Pharmacies
      3. Others
   6. Market Attractiveness Analysis
9. East Asia Anti-Obesity Prescription Market Outlook
   1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product Type
      3. By Mechanism
      4. By Distribution Channel
   2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
      1. China
      2. Japan
      3. South Korea
   3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
      1. Approved Drugs
      2. Off Label Drugs
   4. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
      1. Peripherally Acting Drugs
      2. Centrally Acting Drugs
   5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
      1. Retail Pharmacies
      2. Hospitals Pharmacies
      3. Others
   6. Market Attractiveness Analysis
10. South Asia & Oceania Anti-Obesity Prescription Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Product Type
       3. By Mechanism
       4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
       1. India
       2. Indonesia
       3. Thailand
       4. Singapore
       5. ANZ
       6. Rest of South Asia & Oceania
    3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
       1. Approved Drugs
       2. Off Label Drugs
    4. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
       1. Peripherally Acting Drugs
       2. Centrally Acting Drugs
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
       1. Retail Pharmacies
       2. Hospitals Pharmacies
       3. Others
    6. Market Attractiveness Analysis
11. Latin America Anti-Obesity Prescription Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Product Type
       3. By Mechanism
       4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
       1. Approved Drugs
       2. Off Label Drugs
    4. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
       1. Peripherally Acting Drugs
       2. Centrally Acting Drugs
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
       1. Retail Pharmacies
       2. Hospitals Pharmacies
       3. Others
    6. Market Attractiveness Analysis
12. Middle East & Africa Anti-Obesity Prescription Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2024
       1. By Country
       2. By Product Type
       3. By Mechanism
       4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2025-2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    3. Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2025-2032
       1. Approved Drugs
       2. Off Label Drugs
    4. Market Size (US$ Bn) Analysis and Forecast, By Mechanism, 2025-2032
       1. Peripherally Acting Drugs
       2. Centrally Acting Drugs
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2025-2032
       1. Retail Pharmacies
       2. Hospitals Pharmacies
       3. Others
    6. Market Attractiveness Analysis
13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping By Market
       2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       1. Novo Nordisk A/S
          1. Overview
          2. Segments and Product Type
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. GlaxoSmithKline plc
       3. Novartis AG
       4. VIVUS LLC
       5. Currax Pharmaceuticals
       6. Kintai Therapeutics
       7. Boehringer Ingelheim International GmbH
       8. Rhythm Pharmaceuticals, Inc.
       9. Gelesis
       10. Others
14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations